Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6856381 | 0.80 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL1539652 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL9226165 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL31124932 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL4447745 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL7208330 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL6912962 | 0.76 | HTR6 (0.44) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL6911689 | 0.76 | HTR6 (0.41) | HTR6HTR2ASIGMAR1 | |
| SCHEMBL9846103 | 0.75 | HTR6 (0.38) | HTR6 | |
| SCHEMBL7204965 | 0.75 | HTR6 (0.43) | HTR6HTR2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020115801-A1 | Process for preparing and using meso/racemic-[bis (indenyl) ethane] zirconium dichloride compounds | RAZAVI ABBAS (BE) | 2002-08-22 | — | — | US | claimed |
| US-6103656-A | Process for preparing and using meso/racemic-[bis (indenyl) ethane]zirconium dichloride compounds | FINA RESEARCH, S.A. (BE) | 2000-08-15 | — | — | US | claimed |
| EP-0835886-A1 | Process for preparing and using meso/racemic-(bis(indenyl)ethane)zirconium dichloride compounds | FINA RESEARCH S.A. (BE) | 1998-04-15 | — | — | EP | claimed |
| EP-0798315-B1 | Process for preparing highly active, stable metallocene catalyst systems, and catalyst compositions prepared according therewith | WITCO GMBH (DE) | 1997-10-29 | — | — | EP | claimed |
| JP-10130322-A | — | — | None | — | — | JP | disclosed |
| US-11919980-B2 | Dual catalyst composition | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2024-03-05 | — | — | US | disclosed |
| EP-3661983-B1 | DUAL CATALYST COMPOSITION | TOTAL RES & TECHNOLOGY FELUY (BE) | 2022-01-19 | — | — | EP | disclosed |
| EP-3661982-B1 | DUAL CATALYST COMPOSITION | TOTAL RES & TECHNOLOGY FELUY (BE) | 2021-12-01 | — | — | EP | disclosed |
| US-20210155724-A1 | Dual Catalyst Composition | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2021-05-27 | — | — | US | disclosed |
| US-20210087311-A1 | Dual Catalyst Composition | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2021-03-25 | — | — | US | disclosed |
| EP-3661982-A1 | DUAL CATALYST COMPOSITION | Total Research & Technology Feluy (BE) | 2020-06-10 | — | — | EP | disclosed |
| EP-3661983-A1 | DUAL CATALYST COMPOSITION | Total Research & Technology Feluy (BE) | 2020-06-10 | — | — | EP | disclosed |
| EP-0835886-A1 | Process for preparing and using meso/racemic-(bis(indenyl)ethane)zirconium dichloride compounds | FINA RESEARCH S.A. (BE) | 1998-04-15 | — | — | EP | disclosed |
| EP-0835886-A1 | Process for preparing and using meso/racemic-(bis(indenyl)ethane)zirconium dichloride compounds | FINA RESEARCH S.A. (BE) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997025336-A1 | PREPARATION OF BISCYCLOPENTADIENYL DIENE COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 1997-07-17 | — | — | WO | disclosed |
| EP-0775148-A1 | BISCYCLOPENTADIENYL DIENE COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1997014727-A1 | HOMOGENEOUS METALLOCENE-BASED OLEFIN POLYMERIZATION SYSTEM WITH INCREASED ACTIVITY | AMOCO CORPORATION (US) | 1997-04-24 | — | — | WO | disclosed |
| US-5616664-A | Polymerization process with biscyclopentadienyl diene complex containing catalysts | THE DOW CHEMICAL COMPANY (US) | 1997-04-01 | — | — | US | disclosed |
| US-5527929-A | Zwitterionic biscyclopentadienyl complexes | THE DOW CHEMICAL COMPANY (US) | 1996-06-18 | — | — | US | disclosed |
| WO-1996004290-A1 | BISCYCLOPENTADIENYL DIENE COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11919980-B2 | Dual catalyst composition | INF2, DUOX2, CPNE4 | HTR6 4399/4885HTR2A 2321/4885SIGMAR1 3869/4885 |
| US-20210087311-A1 | Dual Catalyst Composition | INF2, DUOX2, CPNE4 | HTR6 4399/4885HTR2A 2321/4885SIGMAR1 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.